CCN6 and breast carcinoma: Clinical samples confirm a correlation between low CCN6 and high IMP2 in spindle and squamous MBC, highlighting a CCN6/IMP2 axis with therapeutic implications and illustrating the diverse mechanisms through which IMP2 contributes to breast cancer progression.